# Twice-daily Tacrolimus and Everolimus Convert to Once-daily Tacrolimus and Everolimus in Liver Transplant Recipient

> **NCT03256864** · PHASE4 · COMPLETED · sponsor: **Chang Gung Memorial Hospital** · enrollment: 10 (actual)

## Conditions studied

- Liver Transplantation

## Interventions

- **DRUG:** Tacrolimus and Everolimus

## Key facts

- **NCT ID:** NCT03256864
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2019-06-30
- **Final completion:** 2020-05-30
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2020-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03256864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03256864, "Twice-daily Tacrolimus and Everolimus Convert to Once-daily Tacrolimus and Everolimus in Liver Transplant Recipient". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03256864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*